SCHEMBL23670689

SCHEMBL23670689

COC(OC)C1(COc2cc(F)c(N)cc2C(=O)O)CCCc2cc(Cl)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4C Q9H3R0 1/20 0.37
▸ GAA P10253 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ APLNR P35414 1/20 0.33
▸ KDM1A O60341 1/20 0.33
▸ PPARG P37231 1/20 0.32
▸ PPARD Q03181 1/20 0.32
▸ PPARA Q07869 1/20 0.32
▸ MRGPRX4 Q96LA9 2/20 0.32
▸ PTGDR Q13258 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.32
▸ PTPN1 P18031 1/20 0.32
▸ SIGMAR1 Q99720 2/20 0.31
▸ CPT2 P23786 2/20 0.31
▸ CPT1A P50416 2/20 0.31
▸ CPT1B Q92523 2/20 0.31
▸ CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23671128 0.93 KDM4C (0.37) KDM4CGAAALDH1A1POLBHPGD
SCHEMBL29553798 0.92 ABL1 (0.36) KDM4CGAAKDM1APPARGPPARD
SCHEMBL23669554 0.92 ABL1 (0.36) KDM4CGAAKDM1APPARGPPARD
SCHEMBL23669556 0.92 ABL1 (0.36) KDM4CGAAKDM1APPARGPPARD
SCHEMBL23669600 0.88 KDM4C (0.40) KDM4CGAAALDH1A1POLBHPGD
SCHEMBL29554530 0.87 ABL1 (0.36) KDM4CKDM1A
SCHEMBL23669352 0.87 KDM4C (0.35) KDM4CALDH1A1HPGDAPLNRPPARG
SCHEMBL23669537 0.83 KDM4C (0.35) KDM4CALDH1A1HPGDAPLNRMRGPRX4
SCHEMBL23442624 0.83 KDM1A (0.39) KDM4CALDH1A1POLBKDM1APPARG
SCHEMBL23688339 0.80 KDM4E (0.34) KDM4CALDH1A1HPGDKDM1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210230189-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN AMGEN INC. (US) 2021-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230189-A1 COMPOUNDS THAT INHIBIT MCL-1 PROTEIN MCL1, BCL9, BCL2L1 KDM4C 3483/4885GAA 2465/4885ALDH1A1 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback